Maternal serum α-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome
- 31 October 1998
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 179 (4) , 966-970
- https://doi.org/10.1016/s0002-9378(98)70198-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Down syndrome prevention program in a population with an older maternal agePublished by Wolters Kluwer Health ,2000
- α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndromeAmerican Journal of Obstetrics and Gynecology, 1997
- Comparion of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥35 years oldAmerican Journal of Obstetrics and Gynecology, 1995
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningNew England Journal of Medicine, 1994
- Detection of fetal Turner syndrome with multiple-marker screeningAmerican Journal of Obstetrics and Gynecology, 1994
- Evaluation of multiple-marker screening for Down syndrome in a statewide populationAmerican Journal of Obstetrics and Gynecology, 1993
- Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndromeAmerican Journal of Obstetrics and Gynecology, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Prenatal screening for trisomy 18 in the second trimesterPrenatal Diagnosis, 1990
- Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988